Abiomed
ABMD
#1257
Rank
ยฃ12.89 B
Marketcap
ยฃ286.01
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : ยฃ0.11 Billion

According to Abiomed's latest financial reports the company's total liabilities are ยฃ0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31ยฃ0.12 B8.29%
2021-03-31ยฃ0.11 B-1.83%
2020-03-31ยฃ0.12 B34.92%
2019-03-31ยฃ90.19 M30.73%
2018-03-31ยฃ68.99 M-12.01%
2017-03-31ยฃ78.4 M104.24%
2016-03-31ยฃ38.39 M21.63%
2015-03-31ยฃ31.56 M41.97%
2014-03-31ยฃ22.23 M2.63%
2013-03-31ยฃ21.66 M25.48%
2012-03-31ยฃ17.26 M3.11%
2011-03-31ยฃ16.74 M18.45%
2010-03-31ยฃ14.13 M2.32%
2009-03-31ยฃ13.81 M13.55%
2008-03-31ยฃ12.16 M69.47%
2007-03-31ยฃ7.17 M37.1%
2006-03-31ยฃ5.23 M102.06%
2005-03-31ยฃ2.59 M-0.3%
2004-03-31ยฃ2.59 M-34.42%
2003-03-31ยฃ3.96 M-44.62%
2002-03-31ยฃ7.15 M8.48%
2001-03-31ยฃ6.59 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Teleflex
TFX
ยฃ3.04 B 2,483.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
ยฃ14.32 B 12,069.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
ยฃ0.11 B 1.39%๐Ÿ‡บ๐Ÿ‡ธ USA